HÖHabibe Övet

Habibe Övet

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Habibe Övet has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    COVID-19 Pnömonili Hastaların Solunum Yolu Örneklerinde Sekonder Bakteriyel Ajanlar ve Antibiyotik Direnç Profilleri

    by Oya Akkaya, Ayşe Rüveyda UĞUR, Habibe Övet, Feyza Alp, Mustafa Önder Gönen

    Objective: To assess secondary bacterial pneumonia agents and antibiotic resistance rates in patients with COVID-19 pneumonia and to compare findings with the pre-pandemic period. Materials and Methods: Bacteria grown in endotracheal aspirate fluid and bronchoalveolar fluid samples of patients diagnosed with COVID-19 between January 2020 and December 2020, and antibiotic resistance rates were retrospectively compared with samples of the year before the pandemic. Isolates were identified at the species level with an automated system (VITEK 2, bioMérieux, France), and antimicrobial susceptibility was determined according to EUCAST criteria. Results: A total of 900 culture results were examined in 2019. Acinetobacter baumannii was detected in 36%, Klebsiella pneumoniae in 23%, Pseudomonas aeruginosa in 14%, and Staphylococcus aureus in 8%. In 2020, 660 culture results were examined, and the same bacteria were detected in 43%, 23%, 16%, and 5%, respectively. K. pneumoniae's resistance to third-generation cephalosporins, and A. baumannii's resistance to gentamycin and tobramycin, were found to have increased significantly during the pandemic period. Conclusions: The growth of multidrug-resistant Gram-negative bacteria was frequently detected in respiratory secretions obtained during the COVID-19 pandemic. Regional bacterial agents and antibiotic resistance profiles should be clarified, and empirical therapy should be selected accordingly in COVID-19.


  • Open Access

    COVID-19 Real Time PCR Test Sonuçlarının PCR Cihazı ve CAtenA Smart PCR Bioinformatik Programı Üzerinden Değerlendirme Sürelerinin Karşılaştırılması

    by Ayşe Rüveyda UĞUR, Habibe Övet

    The COVID-19 pandemic, which was caused by the SARS-CoV-2 virus, emerged in Wuhan, China in December 2019, and has had a detrimental impact worldwide. The nucleic acid amplification tests are the recommended method for the diagnosis of COVID-19. CAtenA Smart PCR is an artificial intelligence-based bioinformatics tool that assists with PCR data interpretation and offers conclusion preferences before transaction to the web-based result systems. The aim of this study was to compare the turnaround times between the data analysis on a PCR instrument, including result submission, and the CAtenA Smart PCR-assisted analysis. The specialists assessed 139 PCR data sets, each with 94 samples and two internal controls, that were performed in the COVID-19 PCR Diagnostic Laboratory at Meram State Hospital in Konya between 1 September and 30 November 2021. The data analysis times for the PCR tool (Bio-Rad CFX96 Touch, Singapore) and the CAtenA Smart PCR Bioinformatics Program (Ventura, Ankara, Turkey) were recorded. The mean time duration of the 139 PCR data analyses for the PCR device was 14.05 ± 7.55 and 8.04 ± 3.93 minutes for the CAtenA. The Wilcoxon signed ranks test was used for the statistical analysis. The difference between the turnaround times for the PCR instrument and CAtenA Smart PCR was found to be statistically significant (p = 0.0001). We further divided the study period into two groups: the high-positivity phase and the low-positivity phase. We compared the two phases in order to assess the effect of the case positivity rates on the turnaround times. There was a significant difference between the turnaround times of the two groups (p = 0.0001). The findings showed that the positivity rate has affected the time duration of data analysis on both the PCR instrument and the CAtenA program. As a result, employing artificial intelligence-based CAtenA Smart PCR to interpret PCR data and send transactions to the web-based result systems reduces the time it takes to complete the task and gives the user more convenience.